UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma

Terapevtic̆eskii arhiv, 2020-12, Vol.92 (12), p.172-179

2020

Volltextzugriff (PDF)

Clinical and economic analysis of Reslizumab use in the treatment of patients with severe allergic eosinophilic asthma

Terapevtic̆eskii arhiv, 2019-12, Vol.91 (12), p.47-56

2019

Volltextzugriff (PDF)

Methodology for Creating a Risk Management System for Drug-Drug Interactions

Antibiot Khimioter = Antibiotics and Chemotherapy, 2024-03, Vol.68 (11-12), p.49-58

2024

Volltextzugriff (PDF)

Readers’ preferences of Irkutsk residents in late of XIX–early XX centuries

Omskij naučnyj vestnik. Seriâ "Obŝestvo. Istoriâ. Sovremennostʹ", 2020-05, Vol.5 (2), p.42-47

Zhuravleva, M. V.

2020

Volltextzugriff (PDF)

Clinical and economic analysis of the use of the medicinal product dapagliflozin in patients with chronic heart failure and type 2 diabetes mellitus

Sakharnyĭ diabet, 2024-07, Vol.27 (3), p.265-276

2024

Volltextzugriff (PDF)

Cost-effectiveness of dapagliflozin as part of various treatment regimens for prevention of cardiovascular death and achieving the target indicator "Reduction of cardiovascular mortality" of the State Program "HealthCare Development" in patients with heart failure with reduced ejection fraction

Rossiĭskiĭ kardiologicheskiĭ zhurnal, 2024-08, Vol.29 (7), p.6027

2024

Volltextzugriff (PDF)

Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia

Farmakoèkonomika (Moskva. Online), 2023-11, Vol.16 (3), p.456-465

2023

Volltextzugriff (PDF)

Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy

Farmakoèkonomika (Moskva. Online), 2023-07, Vol.16 (2), p.149-161

2023

Volltextzugriff (PDF)

Development of methodological approaches to the formation of a risk-based model to minimize the prevalence of adverse reactions in drug application in medical organizations of Moscow

Farmakoèkonomika (Moskva. Online), 2023-07, Vol.16 (2), p.248-257

2023

Volltextzugriff (PDF)

Antioxidant enzymes and reactive oxygen species level of the Achromobacter xylosoxidans bacteria during hydrocarbons biotransformation

Archives of microbiology, 2018-09, Vol.200 (7), p.1057-1065

2018

Volltextzugriff (PDF)

Assessment of The Toxicological Profile of The New Dioxidine Dosage Form (Solution for Topical and External Use, 0.025%)

Antibiotics and Chemotherapy, 2022-11, Vol.67 (7-8), p.24-32

2022

Volltextzugriff (PDF)

Contribution of ticagrelor therapy in patients with acute coronary syndrome and patients with myocardial infarction to the achievement of State Program "Health Development" target in Russia as a whole and Russian regions in 2023-2025

Rossiĭskiĭ kardiologicheskiĭ zhurnal, 2024-02, Vol.29 (1), p.5700

2024

Volltextzugriff (PDF)

The Impact of Combination Therapy with Rivaroxaban and Acetylsalicylic Acid in Patients with Coronary Heart Disease on the Achievement of the Target for Reducing Mortality from Cardiovascular Diseases of the Federal Project "Fight against Cardiovascular Diseases"

Rat͡s︡ionalʹnai͡a︡ farmakoterapii͡a︡ v kardiologii, 2022-03, Vol.18 (1), p.56-66

2022

Volltextzugriff (PDF)

Cost-effectiveness of valsartan+sakubitril, dapagliflosin and empagliflosin for prevention of cardiovascular death and reducing cardiovascular mortality within the State Program "Health Development" in patients with heart failure

Rossiĭskiĭ kardiologicheskiĭ zhurnal, 2023-12, Vol.28 (12), p.5711

2023

Volltextzugriff (PDF)

Сost-effectiveness of preventing cardiovascular death and achieving the target indicator "Reduction of the cardiovascular mortality of the population" of the State Program "Health Development" when using valsartan+sacubitril, dapagliflozin and empagliflozin in patients with heart failure with reduced ejection fraction

Rossiĭskiĭ kardiologicheskiĭ zhurnal, 2023-04, Vol.28 (3), p.5386

2023

Volltextzugriff (PDF)

Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings

Farmakoèkonomika (Moskva. Online), 2022-07, Vol.15 (2), p.175-186

2022

Volltextzugriff (PDF)

Clinical Pharmacology of Antimicrobials: Focus on the Safety of Vancomycin and Linezolid

Bezopasnostʹ i risk farmakoterapii (Online), 2023-12, Vol.11 (4), p.430-441

2023

Volltextzugriff (PDF)

Retrospective Analysis of the Initial Empirical Antibiotic Therapy Effectiveness for Community-Acquired Pneumonia in Young Individuals in Moscow Multidisciplinary Hospital

Antibiotics and Chemotherapy, 2022-12, Vol.67 (9-10), p.55-62

2022

Volltextzugriff (PDF)

Application of the cost-effectiveness method in improving the pharmacotherapy of multiple myeloma

Kachestvennai͡a︡ klinicheskai͡a︡ praktika, 2023-04 (1), p.15-25

2023

Volltextzugriff (PDF)

Pharmacoeconomic analysis of using empegfilgrastim for the treatment of early and locally advanced HER2+ breast cancer in the Russian Federation

Farmakoèkonomika (Moskva. Online), 2024-02, Vol.16 (4), p.537-549

2024

Volltextzugriff (PDF)

Strategy and Control of Antimicrobial Therapy Program Implementation at the B.V. Petrovsky National Research Center of Surgery

Antibiotics and Chemotherapy, 2020-12, Vol.65 (9-10), p.44-50

2020

Volltextzugriff (PDF)

SYNERGIC EFFECT OF PREPARATION WITH COORDINATION COMPLEX “TRIMETHYDRAZINIUM PROPIONATE+ETHYMTH METHYLHYDROXYPIRIDINE SUCCINATE” ON ENERGY METABOLISM AND CELL RESPIRATION

Farmaciâ i Farmakologiâ (Pâtigorsk), 2022-01, Vol.10 (4), p.387-399

2022

Volltextzugriff (PDF)

Effect of dapagliflozin therapy on achieving cardiovascular mortality target indicators in patients with heart failure

Rossiĭskiĭ kardiologicheskiĭ zhurnal, 2022-01, Vol.26 (12), p.4800

2022

Volltextzugriff (PDF)

Evaluation of the effect of the use of the drug ticagrelor in patients with acute coronary syndrome on achieving the target indicator “reduction of mortality from diseases of the circulatory system” in 2022-2024

Rossiĭskiĭ kardiologicheskiĭ zhurnal, 2022-01, Vol.26 (12), p.4819

2022

Volltextzugriff (PDF)

Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia

Bezopasnostʹ i risk farmakoterapii (Online), 2022-07, Vol.10 (2), p.96-109

2022

Volltextzugriff (PDF)

1 – 25 von 764

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(617)
Mit Volltextzugriff
(376)

Publikationsform

Sprache

Englisch
(613)
Russisch
(235)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma

Clinical and economic analysis of Reslizumab use in the treatment of patients with severe allergic eosinophilic asthma

Methodology for Creating a Risk Management System for Drug-Drug Interactions

Readers’ preferences of Irkutsk residents in late of XIX–early XX centuries

Clinical and economic analysis of the use of the medicinal product dapagliflozin in patients with chronic heart failure and type 2 diabetes mellitus

Cost-effectiveness of dapagliflozin as part of various treatment regimens for prevention of cardiovascular death and achieving the target indicator "Reduction of cardiovascular mortality" of the State Program "HealthCare Development" in patients with heart failure with reduced ejection fraction

Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia

Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy

Development of methodological approaches to the formation of a risk-based model to minimize the prevalence of adverse reactions in drug application in medical organizations of Moscow

Antioxidant enzymes and reactive oxygen species level of the Achromobacter xylosoxidans bacteria during hydrocarbons biotransformation

Assessment of The Toxicological Profile of The New Dioxidine Dosage Form (Solution for Topical and External Use, 0.025%)

Contribution of ticagrelor therapy in patients with acute coronary syndrome and patients with myocardial infarction to the achievement of State Program "Health Development" target in Russia as a whole and Russian regions in 2023-2025

The Impact of Combination Therapy with Rivaroxaban and Acetylsalicylic Acid in Patients with Coronary Heart Disease on the Achievement of the Target for Reducing Mortality from Cardiovascular Diseases of the Federal Project "Fight against Cardiovascular Diseases"

Cost-effectiveness of valsartan+sakubitril, dapagliflosin and empagliflosin for prevention of cardiovascular death and reducing cardiovascular mortality within the State Program "Health Development" in patients with heart failure

Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings

Clinical Pharmacology of Antimicrobials: Focus on the Safety of Vancomycin and Linezolid

Retrospective Analysis of the Initial Empirical Antibiotic Therapy Effectiveness for Community-Acquired Pneumonia in Young Individuals in Moscow Multidisciplinary Hospital

Application of the cost-effectiveness method in improving the pharmacotherapy of multiple myeloma

Pharmacoeconomic analysis of using empegfilgrastim for the treatment of early and locally advanced HER2+ breast cancer in the Russian Federation

Strategy and Control of Antimicrobial Therapy Program Implementation at the B.V. Petrovsky National Research Center of Surgery

SYNERGIC EFFECT OF PREPARATION WITH COORDINATION COMPLEX “TRIMETHYDRAZINIUM PROPIONATE+ETHYMTH METHYLHYDROXYPIRIDINE SUCCINATE” ON ENERGY METABOLISM AND CELL RESPIRATION

Effect of dapagliflozin therapy on achieving cardiovascular mortality target indicators in patients with heart failure

Evaluation of the effect of the use of the drug ticagrelor in patients with acute coronary syndrome on achieving the target indicator “reduction of mortality from diseases of the circulatory system” in 2022-2024

Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia

Suchergebnisse filtern